This study investigates and compares biotech pharmaceutical business models among China, Japan and the U.S. It finds significant differences among the three countries in i) R&D innovation, ii) market penetration, and iii) human capital extraction. As a result, firms in these countries...

Chapter 1: The Chinese healthcare and pharmaceutical market: Ignore at your own peril -- Chapter 2: China regulatory and legal reforms: Gateway to innovation and global integration -- Chapter 3: The golden age of the Chinese biopharma: Explosive growth in a thriving ecosystem -- Chapter 4:...